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Abstract:  
Vitamin E is a mixture of eight compounds α, β, γ, δ- tocopherols and α, β, γ, δ- tocotrienols. Their individual role in cellular 
transport as antioxidants and in metabolic pathways has been highlighted in the present work. All the eight compounds have 
been docked  with the respective metabolizing enzymes (α-tocopherol transfer protein (ATTP), α-tocopherol associated 
protein (TAP), P-glycoprotein (P-gly) and human serum albumin (HSA)) to understand molecular interactions for 
pharmacokinetics. These have been structurally aligned against the four human phospholipids in order to reveal their 
individual role in chylomicron formation and hence the mechanism of cellular transport. The study of their binding with their 
metabolizing enzymes provides insight to the comparative antioxidant activity of each of these isomers.  
 
Background: 
It has now been  realized that Vitamin E, traditionally 
known as α- tocopherol, is a  mixture of eight different 
compounds, four tocopherols and four tocotrienols, each 
one being designated as α,  β,  γ and δ forms. The two 
groups differ in the hydrophobic tridecyl side chain which 
is saturated (phytyl) in tocopherols and unsaturated having 
three double bonds (geranyl) in tocotrienols. Detailed 
reports are available on α-tocopherol. However, during the 
last few years it has been found that all the eight forms are 
biologically active and perform specific functions. Clinical 
research has shown that mixture of tocotrienols and 
tocopherols offer synergistic protective action against heart 
ailments and cancer that is not exclusively offered by α-
tocopherol. The other advantage of mixed tocopherols and 
tocotrienols is their role in slowing down aging. Diseases 
like diabetes 1 and 2, autoimmune diseases, bacterial and 
viral infections, Alzheimer disease, fungal (Candida) 
infections are prevented by these compounds. It helps in 
the maintenance of bones, muscles, eyes (vision), memory, 
sleep, lungs, infertility, skin and wrinkles. [1] 
 
The main function of α-Tocopherol is to terminate a chain 
reaction of lipid peroxidation and thus protecting the cell 
membranes and LDL from oxidative disintegration. It has 
been reported in literature that the cell signaling activity of 
the enzyme protein kinase C is considerably reduced due to 
the presence of α-tocopherol  [2]. This also affects the 
activity of both inflammatory and immune cells [3].  α-
Tocopherol also dilates blood vessels and interferes with 
aggregation of platelets. Recent reports have suggested 
better activity of γ-tocopherol Vis-a-Vis α-tocopherol. γ-
tocopherol can trap NO and other nitrogen free radicals 
more efficiently than α-tocopherol  [4].  γ-Tocopherol is 
known to have a balanced effect on the transport of Na+ 
(sodium ions) thus affecting beneficially the uretic activity 
[5]. δ-Tocopherol and its metabolites have been found to 
be the most effective inhibitors for the proliferation of 
prostate cancer cells [6].  
 
γ-Tcopherol has unique properties unlike alpha-tocopherol 
including the ability to neutralize certain free radicals and 
suppress expression of a gene (ras-p21) that is known to 
cause cancer [7]. Stone and colleagues have reported that 
γ-tocopherol can hinder the growth of colon cancer [8]. An 
interesting observation has been reported elsewhere [9], 
that if α and γ-tocopherols are taken up together into the 
cells, the γ-tocopherol increases the level of α-tocopherol. 
It has been reported that excess of α-tocopherol displaces 
the more important gamma component in the body.  The 
cellular uptake of tocotrienols through lipid bilayer is more 
due to the presence of double bonds in their side chains, 
enhancing their bioavailability and hydrophobicity. This 
makes them potentially more useful for cosmetic products. 
It is evident from the fact that amongst the two  α- 
components,   the α-tocotrienol has been found  to be 40 to 
60 times more potent than α-tocopherol in preventing lipid 
peroxidation and 6.5 times better at defending cytochrome 
P-450 against oxidative damage. The efficiency of α-
tocotrienol in scavenging peroxyl radicals in liposomes is 
1.5 fold more than α-tocopherol. 
 
It is found that δ-tocotrienol is uniformly distributed in cell 
membranes due to its hydrophobic nature which is due to 
its unsaturated side chain. δ- tocotrienol has been shown to 
possess anti-thrombic activity and decreases platelet 
aggregation.  δ-tocotrienol is the most effective form of 
vitamin E family in reducing the risk of developing 
atherosclerotic plaque. One of the most striking discoveries 
in tocotrienol research is their ability to clear 
atherosclerotic blockages (stenosis) in the carotid artery, 
potentially reducing the risk of stroke. These are more 
potent in quenching and scavenging the free radicals. Due 
to their molecular structure they have greater recycling 
activity and more effective collusion with free radicals [10].  
 
One of the metabolite of γ-tocotrienol is LLU-alpha which 
reduces the high blood pressure and congestive heart Bioinformation by Biomedical Informatics Publishing Group                             open access 
www.bioinformation.net                                                              Hypothesis 
___________________________________________________________________________ 
 
ISSN 0973-2063 (online) 0973-8894 (print)  
Bioinformation 3(8): 326-331 (2009)  
               Bioinformation, an open access forum  
    © 2009 Biomedical Informatics Publishing Group 
327
failure [11]. Tocotrienols inhibit cancer cell proliferation 
through apoptosis. Studies on estrogen responsive and 
estrogen non-responsive human breast cancer cells have 
shown that tocotrienols are effective in preventing the 
proliferation of both [12]. Tocotrienols inhibit NF kB 
signaling pathway leading to suppression of antiapoptotic 
gene products and starts apoptosis. Tocotrienols are known 
to cross the blood-brain barrier, and are potent protectors 
of neuron cells that may get destroyed through stroke and 
other neurodegenerative diseases. 
 
The reports discussed thus far about the enhanced activity 
of other members of the vitamin E family besides the 
mostly studied α-tocopherol, motivated us to study the 
structure-activity relationship of the whole group. It is 
known that α-tocopherol is taken up together
 with dietary 
lipids and bile in the proximal part of the intestine.
 The 
tocopherols get assembled together with triglycerides, 
cholesterol,
  phospholipids, and apolipoproteins into 
chylomicrons. The exact mechanism of this process of 
chylomicron formation is not very well known. In this 
paper we have made an effort  to structurally align all the 
four  mammalian phospholipids viz. phosphatidyl choline, 
phosphatidyl ethanolamine, phophatidyl inositol, 
lysophosphatidyl inositol , present in the human liver with 
tocopherols and tocotrienols  to establish their mechanism 
of action. 
 
Methodology: 
ACD/CHEMSKETCH:   
2-D structures of all the eight compounds of vitamin E 
were developed using ACD/chemsketch software (to draw 
molecules, reactions and schematic diagrams and calculate 
their properties).  
 
CHIMERA:  
3-D structures of all the eight isomers of vitamin E were 
obtained from chimera (python based software generates 
three dimensional atomic coordinates from 2-D structure of 
a molecule).  
 
AUTODOCK:  
Docking was performed using AUTODOCK version 3.0 
software package running on PC Intel-based Pentium 4, 
running Linux operating system. 
 
Protein receptors for docking: 
The following four target proteins were selected for the 
study, 
 
Alpha-tocopherol transfer protein (ATTP) 
Alpha-tocopherol (α-T) transfer protein (ATTP) is a 
member of the family of lipid-binding proteins containing 
two CRAL-TRIO domains, pfam03765 (residues 11–83) 
and pfam00650 (residues 89–275). The corresponding 
structure with PDB ID 1R51 is downloaded from PDB. 
 
Alpha-tocopherol associated protein (TAP) 
It is tocopherol
 binding protein with a molecular mass of 
46  kDa present in the cytosol of bovine
  liver. This is 
referred as alpha tocopherol-associated protein (TAP). The 
corresponding structure with PDB ID 1OLM is 
downloaded from PDB. 
 
P-glycoprotein (P-gp) 
3-D structure of p-glycoprotein was downloaded from 
PDB (PDB ID 2GHI). P-glycoprotein is found in the gut, 
gonads, kidneys, biliary system, brain and other organs. It 
belongs to the family of efflux transporter. P-gp is also 
called ABCB1, ATP-binding cassette sub-family B 
member 1, MDR1, and PGY1. It is a 170 kDa encoded by 
the MDR (multidrug resistance) gene(s) that are highly 
conserved across species.  
 
Human serum albumin (HSA) 
3-D structure of human serum was downloaded from PDB 
(PDB ID: 1E7H). The protein is a helical monomer of 66 
kDa containing three homologous domains (I-III) each of 
which is composed of A and B sub-domains. 
 
Structural Alignment  
We used the VMD software for structural alignment of the 
phospholipid molecules present in human liver with all the 
eight forms of tocopherols and tocotrienols. The lipid 
structures were first downloaded from lipid database, and 
thereafter the 2D structures were drawn using the 
Chemsketch software. Root mean square deviation was 
then calculated using appropriate tools in Chemsketch. 
 
Molecular docking: 
 
ATTP:  
The PDB ID used for ATTP is 1R51. The crystal structure 
of human alpha-tocopherol transfer protein bound to its 
ligand  α-tocopherol is used. The bound tocopherol was 
removed and the active site of the ligand was analyzed 
with the help of CASTP server. Volume of the active site is 
1030 Å
3 and surface area is 727 Å
2. This active site is 
made of residues TYR100 to ILE222. This is tested for all 
the eight isomers. 
 
TAP:  
The PDB  ID used for TAP is 1OLM. The structure is 
protein complex with rrr-alpha-tocopherylquinone. The 
active site has volume 10262 Å
3 and surface area 6402.2 
Å
2. 
 
HSA:  
The PDB ID used for HSA is 1E7H. HSA forms complex 
with palmitic acid. The volume of the active site (LYS413-
LYS538) 88.7 Å
3 and the surface area is 90.2 Å
2. 
 
 
P-gp: 
The PDB ID used for P-gp is 2GHI. P-gp has four chains 
with ATP binding sites. The volume of the active site 
(LYS37-ILE231) is 10.1 Å
3 and the surface area is 18.9 Å
2.  
 
Docking procedure: 
The active sites are located in each of the target proteins 
before being loaded to AUTODOCK. Polar hydrogens 
were then added using the protonate utility available in 
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rotation to bonds. AUTOGRID (using Kollman united 
atom charges and salvation parameters) is then used to map 
grid to active sites of target protein. The grid dimensions 
are [1.344, 63.053, 14.596] for TTP, [-20.33, 19.575, 
87.289] for TAP, [-3.188, 1.003, 26.114] for HSA and 
[45.57, 14.8, -17.9] for P-gp. The genetic search algorithm 
with 100 iterative runs was selected for dockings.  
 
Discussion: 
We aligned all the structures of eight tocopherols and 
tocotrienols with four human phospholipids to elucidate 
the exact binding mode in the formation of chylomicrons 
before reaching the intestine [13]. Literature reports 
suggest that α-tocopherol along with lipids is packed into 
chylomicrons and transported to the liver [14]. They 
appearance in plasma is only after passing through the liver. 
Most of the ingested
 ß-, γ-, and δ- tocopherols are secreted 
into bile are not taken
 up and hence excreted in the feces. 
This is true for all the other compounds used in this study. 
However, results show that α-tocopherol and α-tocotrienol 
are more structurally similar to phophatidyl inositol. β-
tocopherol is similar to phosphatidyl choline and beta-
tocotrienol is aligned with  phosphotidyl ethanolamine. δ 
and  γ forms are more similar to lysophosphatidyl 
ethanolamine. Nonetheless, all the four phospholipids are 
associated with the transportation process. The binding 
mode of these eight components of vitamin E with 
different proteins in metabolism, transport and absorption 
is of interest. The binding energy of these compounds with 
four metabolizing enzymes is given in Table 1. 
 
Αlpha-tocopherol transfer protein (α-TTP) present in liver 
is selectively involved in retension of α - tocopherol from 
dietary vitamin E (a mixture of α, β, γ, δ tocopherols and 
corresponding tocotrienols). The components of vitamin E 
are taken up along with emulsified lipid molecules, 
extracted from food, in equal amounts in an unspecific 
manner. These are transported from intestine packed in 
chylomicrons and subsequently found as remnants in the 
liver. The cytosolic protein α-TTP is then released into 
circulation from the liver. This enzyme is responsible for 
the stereo-selective transfer of α- tocopherol to VLDL. In 
vitro  and in vivo assays have shown that α- TTP 
preferentially binds to the α-tocopherol. However, our 
docked complex shows that α-tocotrienol shows the 
highest binding affinity among all the eight isomers tested 
for the protein. The other three tocotrienols (β, γ, δ) have 
appreciably high binding energy as compared to the 
corresponding tocopherols. Data also show that the four 
tocopherols have almost equivalent binding energy. We 
then selected the specific active sites for docking of all the 
eight isomers. The docked conformation of α-tocotrienol 
with α- TTP has two hydrogen bonded interaction with α- 
TTP (Figure 1). The interaction is with ser140 of intensity 
-0.28 and with ser136 of intensity -1.26. 
 
Tocopherol-associated protein (TAP) is also been 
documented extensively as a metabolizing enzyme. It is 
present in
 brain, liver and prostate gland. It increases the 
uptake and absorption of Vitamin E and hence facilitates 
the anti proliferation effect in prostate cancer cells. TAP 
also functions like a tumor suppressor gene to control 
cancer cell viability through a non-vitamin E functional 
mechanism. Therefore, TAP is a new prophetic marker for 
prostate cancer progression. TAP is a vitamin-binding 
protein and it is involved in transport of Vitamin 
components specifically tocopherols. Docking data 
suggests that γ-tocotrienol binds better than others. Three 
tocotrienols except δ-tocotrienol have comparable binding 
energies higher affinity than tocopherols. They are easily 
transported between the membranes due to unsaturated 
side chains. Thus, trienols are potential tumor suppressors 
for prostate cancer. Docking data shows that gamma 
tocotrienol have four hydrogen bond interactions with 
active site residues of TAP (Figure 2). The interactions are 
with Ile80 of intensity -0.899, Leu84 of intensity -0.4962, 
Leu84 of intensity -0.30 and Asn259 of intensity -2.203. 
 
HSA is the target protein for circulation of tocopherols and 
tocotrienols through blood. This protein has an ability to 
bind variety of hydrophobic small molecules. These 
include fatty acids, bilirubin, thyroxin, bile acids, steroids 
and a group of other bio active molecules. HSA can 
solubilize the ligands to facilitate transport and buffering 
effect in free concentration. It is documented that HSA 
binds a wide variety of drugs in two primary sites which 
overlap with the binding locations of endogenous ligands 
[15]. We then selected a site specific for palmitic acid. 
Data suggest that γ- tocotrienol and δ-tocotrienol have 
highest binding energy with HSA as compared to other 
members of the family. Overall the binding of tocotrienols 
with HSA is comparatively higher than the four 
tocopherols. The docked conformation of γ- tocotrienol 
with the highest binding energy.-11.34 and docking energy 
is -14.24 kcal/mol. Figure 3 shows the electrostatic 
interactions of γ- tocotrienol with the aminoacid of HAS. 
This shows the better absorption and transport potential of 
tocotrienols. 
 
P-glycoproteins are involved in active transport of various 
ligands across cell membranes through ATP mediated 
processes. These are either localized in the plasma 
membrane or intracellular and are responsible for efflux of 
various foreign substances including drugs. This protects 
the body against toxic xenobiotics and drugs. It prevents 
their accretion in sensitive organs like brain, placenta and 
gonads by removing these compounds into bile, urine, and 
the intestinal lumen. The role played by P-gp efflux 
transporters in assaying the overall bioavailability of drugs 
is emphasized in recent years. The involvement of P-gp in 
drug metabolism has immense pharmacokinetic 
importance. The role of efflux transporters in determining 
the permeability and overall bioavailability of drugs has 
gained considerable attention. P-gp efflux pump is 
localized in a wide range of tissues, including enterocytes 
of the GI tract. The interaction of P-gp with vitamin E 
components highlights their bioavailability and 
pharmacokinetics for distribution in organs/tissues. The 
docked conformation of α-tocotrienol with P-gp shows a 
single hydrogen bond interaction (Figure 4). The 
interaction is with Gln100 of interaction energy -0.781 
kcal/mol, binding energy -9.06 kcal/mol and docking 
energy -11.91 kcal/mol. 
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We selected the ATP binding site for docking of all the 
eight components of vitamin E in order to analyze their 
efflux potential. When binding intensity is high efflux is 
low resulting in more bioavailability. In this study, data 
shows that α- and δ-tocotrienols show highest binding 
affinity at the ATP site. Therefore, it can stop the efflux of 
all other components more efficiently and thus, enhancing 
their bioavailability. The other two tocotrienols (β and γ) 
have comparable activity. Tocotrienols are potent 
candidate as antioxidant and anticancer agent and thus it is 
important to increase their bioavailability. The 
bioavailability of all the components of vitamin E is 
increased when taken with compounds (eg. piperine) that 
bind strongly at the ATP site of P-glycoprotein which 
enhances the bioavailability of many antioxidants like 
curcumin and vitamin C.  
 
 
Figure 1: The docked conformation of α-tocotrienol with α- TTP has two hydrogen bonded interaction with α- TTP. 
 
 
Figure 2: Docking data shows that gamma tocotrienol have four hydrogen bond interactions with active site residues of TAP 
 
 
Figure 3: The electrostatic interactions of γ- tocotrienol with the aminoacid of HSA. 
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Figure 4: The docked conformation of α-tocotrienol with P-gp shows a single hydrogen bonded interaction 
                                             
Conclusion:  
A study to understand the mechanism of cellular uptake of 
phospho-lipids through the formation of chylomicron with 
lipids is of interest. The eight components of vitamin E 
show similar mechanism of cellular uptake (chylomicron 
formation with lipids). The docked complexes of ATTP, 
TAP, HSA and P-gp with tocotrienols and tocopherols 
provide insight to their binding mode during metabolism, 
absorption, transport and efflux. Data shows that the 
tocotrienols with unsaturated side chain show better 
activity than tocopherols due to high binding with the 
corresponding metabolizing enzymes. This suggests 
tocotrienols as potential antioxidants and tumor 
suppressors than tocopherols. Nonetheless, it should be 
noted these docked data should be verified using 
appropriate experiments. 
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Supplementary material 
 
Table1: Binding energies for the docked conformations of eight tocopherols and trienols with four enzymes 
Ligand/Protein  Α  TTP p-glycoprotein HSA TAP 
α-tocopherol -10.61  -7.71  -6.37  -9.76 
α- tocotrienol  -12.1  -9.08  -7.60  -10.82 
β-tocopherol -9.74  -6.89  -6.08  -8.83 
β-tocotrienol -11.46  -8.52  -7.42  -10.73 
δ- tocopherol  -10.39  -7.72  -6.60  -9.13 
δ-tocotrienol -11.68  -9.03  -7.74  -10.85 
γ-tocopherol -10.86  -7.72  -6.50  -8.71 
γ-tocotrienol -11.34  -8.57  -7.80  -11.28 
ATTP = alpha-tocopherol transfer protein; HSA = Human serum albumin; TAP = alpha-tocopherol associated protein 
 
 
 
 